Feed MLAB
ML

Mesa Laboratories, Inc.

MLAB · NASDAQ

$125.29 -0.22% (-$0.27)
1M +18.13%
Market Cap $711.5M
P/E Ratio 148.23x
Div. Yield 0.50%
ROE 2.59%

Bulios Fair Price

$72.77

41.9% downside

Current Price

$125.29

Undervalued Fair Value Overvalued

According to Bulios Fair Price, MLAB is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
7/9
Valuation
48 /100
Fair
P/E 148.23x
EV/EBITDA 19.28x
P/S 2.85x
Growth
51 /100
Stable
Rev. growth 9.34%
FCF growth 6.74%
Book val. growth 25.96%
Profitability
65 /100
Moderate
Gross margin 65.99%
Net margin 1.92%
Op. margin 9.00%
Quality
18 /100
Poor
ROIC 3.12%
ROE 2.59%
ROA 1.14%
Debt
67 /100
Low
Debt/Equity 0.54x
Current ratio 2.07x
Int. coverage 1.62x
Stability
51 /100
Moderate
Beta 0.97x
Rev. volatility 10.20%
EPS volatility 16,101.67%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about MLAB
Online

About the company

Mesa Laboratories is a company focused on providing technological solutions and services in the fields of monitoring, testing, and calibration across industrial sectors. Their products and services encompass a wide range of devices and systems for environmental monitoring, sterilization, pharmaceutical industry, and other areas.

Sector

Healthcare

Industry

Medical - Specialties

CEO

Siddhartha C. Kadia

Employees

717

Headquarters

Lakewood

Upcoming events

05 NOV

Earnings

Upcoming earnings report

50d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.